BK Virus–Associated Nephropathy in Kidney Transplant Recipients

REFERENCES

1. ↵
   1. Randhawa P.,
   2. Brennan D. C.

   (2006) BK virus infection in transplant recipients: an overview and update. Am J Transplant 6((9)):2000–2005, pmid:16771813.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Hirsch H. H.,
   2. Brennan D. C.,
   3. Drachenberg C. B.,
   4. et al.

   (2005) Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79((10)):1277–1286, pmid:15912088.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Comoli P.,
   2. Binggeli S.,
   3. Ginevri F.,
   4. Hirsch H. H.

   (2006) Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 8((2)):86–94, pmid:16734631.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Mischitelli M.,
   2. Bellizzi A.,
   3. Anzivino E.,
   4. et al.

   (2008) Complications post renal transplantation: literature focus on BK virus nephropathy and diagnostic tools actually available. Virol J 3((5)):38, pmid:18315864.

   OpenUrlPubMed
5. ↵
   1. Brennan D. C.,
   2. Agha I.,
   3. Bohl D. L.,
   4. et al.

   (2005) Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction [published correction appears in Am J Transplant. 2005; 5(4, pt 1): 839]. Am J Transplant 5((3)):582–594, pmid:15707414.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Beimler J.,
   2. Sommerer C.,
   3. Zeier M.

   (2007) The influence of immunosuppression on the development of BK virus nephropathy—does it matter? Nephrol Dial Transplant 22((suppl 8)):viii66–viii71, pmid:17890267.

   OpenUrlCrossRefPubMed
7. ↵
   1. Cosio F. G.,
   2. Amer H.,
   3. Grande J. J. P.,
   4. Larson T. S.,
   5. Stegall M. D.,
   6. Griffin M. D.

   (2007) Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. Transplantation 83((4)):411–416, pmid:17318073.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Drachenberg C. B.,
   2. Papadimitriou J. C.,
   3. Hirsch H. H.,
   4. et al.

   (2004) Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 4((12)):2082–2092, pmid:15575913.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Bohl D. L.,
   2. Brennan D. C.

   (2007) BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2((suppl 1)):S36–S46, pmid:17699509.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Drachenberg C. B.,
    2. Papadimitriou J. C.

    (2006) Polyomavirus-associated nephropathy: update in diagnosis. Transpl Infect Dis 8((2)):68–75, pmid:16734629.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. DeMay R. M.

    (1996) The Art and Science of Cytopathology. Vol 1 (American Society Clinical Pathology, Chicago, IL), 75, pp 2160–2161.

    OpenUrl
12. ↵
    1. Viscount H. B.,
    2. Eid A. J.,
    3. Espy M. J.,
    4. et al.

    (2007) Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 84((3)):340–345, pmid:17700158.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Pang X. L.,
    2. Doucette K.,
    3. Leblanc B.,
    4. Cockfield S. M.,
    5. Preidsaitis J. K.

    (2007) Monitoring of polyoma BK viruria and viremia in renal allograft recipients using quantitative real-time PCR assay: one-year prospective study. J Clin Microbiol 45((11)):3568–3573, pmid:17855578.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Alméras C.,
    2. Foulongne V.,
    3. Garrigue V.,
    4. et al.

    (2008) Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 85((8)):1099–1104, pmid:18431228.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Hirsch H. H.,
    2. Knowles W.,
    3. Dickenmann M.,
    4. et al.

    (2002) Prospective study of polyomavirus type BK replication and nephropathy in renal transplant recipients. New Engl J Med 347((7)):488–496, pmid:12181403.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Wali R. K.,
    2. Drachenberg C.,
    3. Hirsch H.

    (2008) Intensive versus routine care screening for polyoma viral reactivation (cluster randomization) and a road map for stepwise modification of immunosuppression therapy (IT). Am J Transplant 8((suppl 2)):283.

    OpenUrl
17. ↵
    1. Vats A.,
    2. Shapiro R.,
    3. Singh Randhawa P.,
    4. et al.

    (2003) Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 75((1)):105–112, pmid:12544881.

    OpenUrlCrossRefPubMedWeb of Science